Akcea Therapeutics, Inc. (AKCA)

Akcea Therapeutics, Inc. (AKCA)

$22.46 USD

0.01 (-0.04%)

Updated Sep 20 12:00am

Add AKCA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

AKCA Daily Price Range
AKCA 52-Week Price Range

AKCA Stock Chart More Charts

AKCA Price/Volume Stats

Current price $22.46
Prev. close $22.47
Day low $21.74
Day high $22.79
50-day MA $21.54
200-day MA $25.68
52-week high $37.73
52-week low $18.68
Volume 416,300
Avg. volume 212,931
Dividend yield N/A
Market Cap 2.09B

Akcea Therapeutics, Inc. (AKCA) Company Bio

Akcea Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The company was founded in 2014 and is based in Cambridge, Massachusetts.

AKCA News Stream

Event/Time News Detail
Loading, please wait...

AKCA Social Stream

Loading social stream, please wait...

View Full AKCA Social Stream

AKCA Returns

1-mo 3.41%
3-mo -7.42%
6-mo -17.85%
1-year -19.73%
3-year N/A
5-year N/A
YTD -25.48%
2018 73.62%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4045 seconds.